MicuRx discovers and develops novel antibiotics to combat drug-resistant bacterial infections. Positioned to capture the benefits of research and development expertise in the U.S. together with the high quality, low cost discovery, preclinical and development infrastructure available in China, the company has built a pipeline of discovery and development programs for the treatment of Gram-positive bacteria, Gram-negative bacteria and fungal infections. The company has research and development facilities outside San Francisco, CA and in Shanghai.

Link to MicuRx China


3916 Trust Way Hayward, CA 94545 USA     email: zyuan@micurx.com       Ph: (510) 782-2021
©MicuRx Pharmaceuticals, Inc. 2010. All rights reserved.